Causes of quitting treatment with varenicline in a smoking cessation clinic

M. Stoleru, S. Mihaicuta (Piatra Neamt, Timisoara, Romania)

Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation
Session: Epidemiology of smoking and smoking cessation
Session type: Thematic Poster Session
Number: 1141
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Stoleru, S. Mihaicuta (Piatra Neamt, Timisoara, Romania). Causes of quitting treatment with varenicline in a smoking cessation clinic. Eur Respir J 2009; 34: Suppl. 53, 1141

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effectiveness of varenicline treatment in a smoking cessation clinic
Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation
Year: 2009


Abundance of smoking cessation reasons in participants of smoking cessation clinic
Source: Annual Congress 2011 - Smoking rate: smoking cessation interventions
Year: 2011

Factors affecting to quit smoking in an outpatient smoking cessation clinic
Source: Annual Congress 2011 - Smoking cessation science and smoking-related disorders
Year: 2011

Factors affecting the success of smoking cessation treatment in a smoking cessation clinic
Source: International Congress 2017 – Smoking cessation
Year: 2017

Results of the smoking cessation treatment in a specialized smoking cessation clinic
Source: Annual Congress 2007 - Smoking cessation
Year: 2007


Predictors of smoking cessation
Source: Annual Congress 2009 - Smoking cessation
Year: 2009


Improvement of quit smoking rate by combining varenicline and nicotine replacement therapy
Source: Annual Congress 2009 - Smoking cessation
Year: 2009


Factors influencing dropout of a smoking cessation consultation in patients treated with varenicline
Source: Annual Congress 2012 - Act to change tobacco epidemics
Year: 2012

Clinical and pathological determinants of abstinence rate in smoking cessation with varenicline
Source: Annual Congress 2010 - Smoking cessation interventions
Year: 2010

Relapse rates following different types of medication treatment through a smoking cessation program
Source: Annual Congress 2006 - How to treat tobacco smokers
Year: 2006


A community-based smoking cessation clinic in Jordan: Profile of smokers who seek treatment and reasons to quit smoking
Source: Annual Congress 2013 –Smoking cessation
Year: 2013

Smoking cessation treatment in smokers with psychiatric problems
Source: Annual Congress 2008 - Towards smoking cessation
Year: 2008


Electronic cigarettes for smoking cessation: an opportunity to readdress smoking cessation treatment
Source: Eur Respir J, 56 (4) 2000098; 10.1183/13993003.00098-2020
Year: 2020



Cost-effectiveness of varenicline for smoking cessation in the Netherlands
Source: Eur Respir J 2007; 30: Suppl. 51, 247s
Year: 2007

Still very few smokers are prescribed smoking cessation medications
Source: ISSN=ISSN 1810-6838, ISBN=, page=172
Year: 2005

e-cigarettes for smoking cessation
Source: International Congress 2015 – E-cigarettes: a wolf in sheep's clothing or a sheep in wolf's clothing?
Year: 2015



Causes of relapses in smoking cessation in women
Source: Annual Congress 2008 - Smoking cessation and new tobacco uses
Year: 2008

Misjudgements among hospital physicians regarding smoking and smoking cessation
Source: Annual Congress 2009 - Smoking cessation
Year: 2009


How to run a smoking cessation clinic
Source: ERS Course 2015
Year: 2015